MarketPeel
Insider Trading Intelligence
MD

Matt Davidson

ADIL
CHIEF DEVELOPMENT OFFICER · ADIAL PHARMACEUTICALS, INC. · CIK 0001741937
FILING MIX · LIFETIME100%/0%
BUYS
6
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2026
HOLDINGS NOW
232,417
AVG SELL PX
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Matt Davidson. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
ADIL · 232,417 shares · as of Jun 12, 2026
074,373148,746223,118297,491SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
FLOW · 6 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
232,417232,417Jun 12, 2026Jun 16, 2026
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
232,417297,491Jun 12, 2026Jun 16, 2026
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,4273,427Jun 11, 2026Jun 16, 2026
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
101.2981,923.428Jun 11, 2026Jun 16, 2026
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
61,64761,647Jun 11, 2026Jun 16, 2026
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,822.131,822.13Jun 11, 2026Jun 16, 2026
Other insiders · ADIL
Loading peer insiders…
About this filer
CIK 0001741937
ROLE
Chief Development Officer
PRIMARY
ADIL
COMPANIES
1
ACTIVE SINCE
Jun 2026
MARKETPEEL · /INSIDER/0001741937DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback